Pleiotropy with sex-specific traits reveals genetic aspects of sex differences in Parkinson's disease.

Conjunctional FDR brain sex-specific gene expression sex-specific age-related gene expression sex-specific eQTLs

Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
06 Sep 2023
Historique:
received: 01 03 2023
revised: 01 08 2023
accepted: 22 08 2023
medline: 6 9 2023
pubmed: 6 9 2023
entrez: 6 9 2023
Statut: aheadofprint

Résumé

Parkinson's disease is an age-related neurodegenerative disorder with a higher incidence in males than females. The causes for this sex difference are unknown. Genome-wide association studies (GWAS) have identified 90 Parkinson's disease risk loci, but the genetic studies have not found sex-specific differences in allele frequency on autosomal chromosomes or sex chromosomes. Genetic variants, however, could exert sex-specific effects on gene function and regulation of gene expression. To identify genetic loci that might have sex-specific effects, we studied pleiotropy between Parkinson's disease and sex-specific traits. Summary statistics from GWASs were acquired from large-scale consortia for Parkinson's disease (n cases=13 708; n controls=95 282), age at menarche (n=368 888 women) and age at menopause (n=69 360 women). We applied the conditional/conjunctional false discovery rate (FDR) method to identify shared loci between Parkinson's disease and these sex-specific traits. Next, we investigated sex-specific gene expression differences in the superior frontal cortex of both neuropathologically healthy individuals and Parkinson's disease patients (n cases=61; n controls=23). To provide biological insights to the genetic pleiotropy, we performed sex-specific expression quantitative trait locus (eQTL) analysis and sex-specific age-related differential expression analysis for genes mapped to Parkinson's disease risk loci. Through conditional/conjunctional FDR analysis we found 11 loci shared between Parkinson's disease and the sex-specific traits age at menarche and age at menopause. Gene-set and pathway analysis of the genes mapped to these loci highlighted the importance of the immune response in determining an increased disease incidence in the male population. Moreover, we highlighted a total of nine genes whose expression or age-related expression in the human brain is influenced by genetic variants in a sex-specific manner. With these analyses we demonstrated that the lack of clear sex-specific differences in allele frequencies for Parkinson's disease loci does not exclude a genetic contribution to differences in disease incidence. Moreover, further studies are needed to elucidate the role that the candidate genes identified here could have in determining a higher incidence of Parkinson's disease in the male population.

Identifiants

pubmed: 37671566
pii: 7261129
doi: 10.1093/brain/awad297
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.

Auteurs

Kaja Nordengen (K)

Department of Neurology, Oslo University Hospital, 0424 Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.

Chiara Cappelletti (C)

Department of Neurology, Oslo University Hospital, 0424 Oslo, Norway.
Department of Mechanical, Electronics and Chemical Engineering, Faculty of Technology, Art and Design, OsloMet - Oslo Metropolitan University, 0130 Oslo, Norway.
Department of Research, Innovation and Education, Oslo University Hospital, 0424 Oslo, Norway.

Shahram Bahrami (S)

Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, 0450 Oslo University Hospital.

Oleksandr Frei (O)

Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, 0450 Oslo University Hospital.

Lasse Pihlstrøm (L)

Department of Neurology, Oslo University Hospital, 0424 Oslo, Norway.

Sandra Pilar Henriksen (SP)

Department of Neurology, Oslo University Hospital, 0424 Oslo, Norway.

Hanneke Geut (H)

Section of Clinical Neuroanatomy and Biobanking, Department of Anatomy and Neurosciences, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam Neuroscience, 1081 Amsterdam, The Netherlands.

Annemieke J M Rozemuller (AJM)

Department of Pathology, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam Neuroscience, 1081 Amsterdam, The Netherlands.

Wilma D J van de Berg (WDJ)

Section of Clinical Neuroanatomy and Biobanking, Department of Anatomy and Neurosciences, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam Neuroscience, 1081 Amsterdam, The Netherlands.

Ole A Andreassen (OA)

Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, 0450 Oslo University Hospital.

Mathias Toft (M)

Department of Neurology, Oslo University Hospital, 0424 Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.

Classifications MeSH